WeedLife News Network

An oil derived from the marijuana plant sharply reduces violent seizures in young people suffering from a rare, severe form of epilepsy, according to a study published Wednesday that gives more hope to parents who have been clamoring for access to the medication.

PUEBLO — If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound’s immense potential as medicine, the “father of cannabis research” said Saturday.

PUEBLO — If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound’s immense potential as medicine, the “father of cannabis research” said Saturday.

Americans are in pain. Over 2.5 million people in the US are addicted to opioids, the US Department of Health and Human Services reports. About 80 die daily from opioid overdoses. It’s gotten so bad that even conservative state legislators want to legalize medical marijuana, arguing it’s a safer, less addictive pain killer.

Much more research is needed to know whether medical cannabis oil may have a wound-healing effect.

ALBUQUERQUE, N.M. — A New Mexico family is suing the state's health department claiming that medical marijuana growing limitations hinder producers from making a certain cannabis oil that helps with their infant daughter's rare disorder.

ALBUQUERQUE, N.M. — A New Mexico family is suing the state's health department claiming that medical marijuana growing limitations hinder producers from making a certain cannabis oil that helps with their infant daughter's rare disorder.

Physicians like Francis D’Ambrosio have substantial reason to believe that cannabinoids may indeed be effective medical treatment.

For the first time in Nebraska, legal testing of a marijuana-based drug treatment will begin this summer.

Cannabis consumers are turning to more discreet concentrates and oils.

DES MOINES, Iowa (AP) — A bill that would create a system for manufacturing, dispensing and possessing medical marijuana in Iowa has advanced in the Legislature with several changes.

Christmas came early for cannabis research scientists. The U.S. Drug Enforcement Agency (DEA) decided to ease some of the regulatory requirements that had been imposed on those who were conducting FDA-approved clinical trials on cannabidiol (CBD).